Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Accidental thio-TEPA poisoning |
Causative agent (attribute) |
False |
Thiotepa (substance) |
Inferred relationship |
Some |
|
Intentional triethylene thiophosphoramide poisoning (disorder) |
Causative agent (attribute) |
False |
Thiotepa (substance) |
Inferred relationship |
Some |
|
Triethylene thiophosphoramide poisoning of undetermined intent |
Causative agent (attribute) |
False |
Thiotepa (substance) |
Inferred relationship |
Some |
1 |
Thiotepa adverse reaction |
Causative agent (attribute) |
True |
Thiotepa (substance) |
Inferred relationship |
Some |
1 |
Allergy to thiotepa (finding) |
Causative agent (attribute) |
False |
Thiotepa (substance) |
Inferred relationship |
Some |
|
Thiotepa overdose |
Causative agent (attribute) |
True |
Thiotepa (substance) |
Inferred relationship |
Some |
1 |
Accidental thiotepa overdose |
Causative agent (attribute) |
True |
Thiotepa (substance) |
Inferred relationship |
Some |
1 |
Intentional thiotepa overdose |
Causative agent (attribute) |
True |
Thiotepa (substance) |
Inferred relationship |
Some |
1 |
surdose de thiotépa d'intention indéterminée |
Causative agent (attribute) |
False |
Thiotepa (substance) |
Inferred relationship |
Some |
1 |
Poisoning by thiotepa |
Causative agent (attribute) |
True |
Thiotepa (substance) |
Inferred relationship |
Some |
1 |
Thiotepa 15mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thiotepa (substance) |
Inferred relationship |
Some |
|
Product containing thiotepa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Thiotepa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely thiotepa 15 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thiotepa (substance) |
Inferred relationship |
Some |
|
Thiotepa 30mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thiotepa (substance) |
Inferred relationship |
Some |
|
Accidental thio-TEPA poisoning |
Causative agent (attribute) |
True |
Thiotepa (substance) |
Inferred relationship |
Some |
1 |
Intentional triethylene thiophosphoramide poisoning (disorder) |
Causative agent (attribute) |
True |
Thiotepa (substance) |
Inferred relationship |
Some |
1 |
Allergy to thiotepa (finding) |
Causative agent (attribute) |
True |
Thiotepa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely thiotepa 15 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Thiotepa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely thiotepa 15 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Thiotepa (substance) |
Inferred relationship |
Some |
1 |
Product containing thiotepa in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Thiotepa (substance) |
Inferred relationship |
Some |
1 |
Thiotepa only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Thiotepa (substance) |
Inferred relationship |
Some |
1 |
Product containing only thiotepa in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Thiotepa (substance) |
Inferred relationship |
Some |
1 |
Thiotepa 15 mg powder for solution for infusion and/or injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Thiotepa (substance) |
Inferred relationship |
Some |
1 |
Thiotepa 15 mg powder for solution for infusion and/or injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Thiotepa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely thiotepa 15 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Thiotepa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely thiotepa 15 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Thiotepa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely thiotepa 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Thiotepa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely thiotepa 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Thiotepa (substance) |
Inferred relationship |
Some |
1 |
Thiotepa 400 mg powder for solution for infusion bag |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Thiotepa (substance) |
Inferred relationship |
Some |
1 |
Thiotepa 400 mg powder for solution for infusion bag |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Thiotepa (substance) |
Inferred relationship |
Some |
1 |